Metabolic
5-Amino-1MQ
Small-molecule NNMT inhibitor studied in metabolic and adipocyte research.
$120
Metabolic
CagriSema Blend
Cagrilintide + Semaglutide
A research blend of cagrilintide and semaglutide for combination metabolic studies.
$149
In stock · ships in 1–2 business days
- ✓ ≥99% purity
- ✓ HPLC + mass-spec tested
- ✓ View component COAs
- ✓ Discreet US shipping
Research Summary
CagriSema is a combination research blend of the amylin analog cagrilintide and the GLP-1 agonist semaglutide, studied in preclinical models examining dual metabolic-signaling pathways. For laboratory research use only.
Handling
Store lyophilized peptide at -20°C and protect from light. After reconstitution with bacteriostatic water, store at 2–8°C and use within the validated stability window. Handle using appropriate laboratory protective equipment.
Certificates of Analysis — Components
CagriSema Blend is a blend of individually certified peptides. Each component below is independently tested by Freedom Diagnostics; open its current batch certificate directly.
Cagrilintide 99.862% HPLC purity · Lot P25091311
Semaglutide 99.30% HPLC purity · Lot 67803
Related Research Peptides
Metabolic
Cagrilintide
A long-acting amylin analog studied in appetite- and energy-balance research.
From $110 Options
Metabolic
Liraglutide
A GLP-1 receptor agonist studied in glucose- and metabolic-signaling research.
From $120 Options